Business

Cannabis is illegal at the federal level in the US. However, 33 states and the District of Colombia have made medical marijuana legal. Also, 11 states and the District of Colombia have made recreational marijuana legal. There’s a huge demand for cannabis in the US, which means more support for legalization. More Americans, including lawmakers, understand marijuana’s health benefits. Marijuana provides employment opportunities and tax revenue to the states. However, cannabis companies don’t get federal business relief during the COVID-19 pandemic.

March's $35.9 million revenue figure was close to the sales results for both January and February.

The latest official monthly sales data for recreational marijuana sales in Illinois have been published. Combined with the previous two months' data, they show that nearly $110 million worth of legal cannabis products were sold in the first quarter of 2020.

Amid drug shortages, could cannabis lessen the burden?

If COVID-19 has made anything clear, it’s the precarious position of many vital global supply chains. One of the most alarming issues is the risk to pharmaceutical production networks. Last month China’s manufacturing and production ground to a halt as the country went into lockdown to contain the virus. This shutdown had an immediate impact on industries around the world, including pharmaceutical ingredients.

Most cannabis stocks have been crushed during the stock market meltdown resulting from the coronavirus pandemic. But this major downturn presents opportunities to buy shares of the strongest players in the cannabis industry at discounted prices.

Illinois’ new recreational marijuana market is off to a hot start even amid the spread of coronavirus. Earlier this week, the state announced nearly $36 million worth of legal cannabis was sold in March — on par with numbers from February.

The weakest companies are succumbing and even relatively healthy firms are showing signs of strain

The cannabis bankruptcy filings are starting to roll in.

Leading High Speed Solvent Recovery Equipment

Electronic devices have changed chemistry. Just as home kitchen counters now feature machines—such as electric kettles and multicookers—that make food preparation more convenient, so modern laboratory benches have dedicated labor-saving devices. For many labs, especially within organic chemistry, one of the most commonly seen and frequently used pieces of equipment is the rotary evaporator. Next-generation, electronic rotary evaporators are beginning to offer tangible and significant performance benefits.

Cannabis investors should expect a bumpy ride.

Marijuana stocks had a rough 2019. The Horizons Marijuana Life Sciences ETF (OTC: HMLSF) fell 39% last year as the S&P 500 rose by 29%. The honeymoon stage for the cannabis industry is long over. And although the outbreak of the coronavirus isn't going to do the industry any favors this year, the reality is that marijuana stocks were going to face problems in 2020 either way.

America’s 243,000-strong legal cannabis workers are rapidly adopting local, state, federal and international health guidelines to keep working as essential businesses during the COVID-19 pandemic.

Regulators have de facto deputized marijuana dispensary operators coast to coast as frontline health care workers—doling out pain and anxiety medication, for starters.

Marijuana stocks were on a rollercoaster ride in March. After struggling in 2019, the marijuana sector didn’t start 2020 on a good note either. The Horizons Marijuana Life Sciences ETF (TSE:HMMJ) tracks the North American cannabis industry. HMMJ fell by 18.8% in March. Overall, the month didn’t start off well for the cannabis sector even before the coronavirus pandemic hit. Surprisingly, while COVID-19 has impacted other sectors, it has helped the cannabis sector. The demand for cannabis increased and sales rose.